- Country: Poland
- Summary: Recombinant Coagulation Factor Viii Concentrate with a Half-Life after a Single Dose of not Less than 35 Hours (One-Step Actin Coagulation Test - Fsl) Together with Successive Deliveries...
- PLT Ref No: 130514475
- Deadline: 04 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 769159-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Recombinant coagulation factor VIII concentrate with a half-life after a single dose of not less than 35 hours (one-step Actin coagulation test - FSL) together with successive deliveries...
1. Two tasks were separated within the contract:
Task 1: Recombinant factor concentrate coagulation VIII with a half-life after a single dose of not less than 35 hours (one-stage Actin coagulation test - FSL) with successive deliveries to Hemophilia Treatment Centers and patients' homes - under the National Health Fund program called "Prevention of bleeding in children with hemophilia A "B".
Task: 2 Recombinant coagulation factor VIII concentrate with a half-life after a single dose of not less than 35 hours (one-stage Actin coagulation test - FSL) with successive deliveries to Regional Blood Donation and Blood Treatment Centers - under the Ministry of Health program entitled "National Program for the Treatment of Patients with Hemophilia and Related Hemorrhagic Disorders for 2024-2028".
2. The Ordering Party requires the Contractor to submit one offer for both tasks constituting the subject of the contract.
programs - The Ordering Party requires that, as part of both tasks, the Contractor offers the same type of recombinant clotting factor VIII concentrate with a half-life after a single dose of not less than 35 hours (one-stage Actin coagulation test - FSL).
Recombinant clotting factor concentrate VIII with a half-life after a single dose of not less than 35 hours (one-step Actin coagulation test - FSL) with successive deliveries to Hemophilia Treatment Centers, Regional... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINRecombinant Coagulation Factor Viii Concentrate with a Half-Life after a Single Dose of not Less than 35 Hours (One-Step Actin Coagulation Test - Fsl) Together with Successive Deliveries... - Poland Tender
The INSTITUTE OF MOTHER AND CHILD, a Government sector organization in Poland, has announced a new tender for Recombinant Coagulation Factor Viii Concentrate with a Half-Life after a Single Dose of not Less than 35 Hours (One-Step Actin Coagulation Test - Fsl) Together with Successive Deliveries.... This tender is published on PolandTenders under PLT Ref No: 130514475 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-04.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
